NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+50.6%
5Y CAGR+26.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+50.6%/yr
vs -3.0%/yr prior
5Y CAGR
+26.5%/yr
Recent acceleration
Acceleration
+53.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $19.20B | +172.6% |
| 2025 | $7.04B | +7.2% |
| 2024 | $6.57B | +16.8% |
| 2023 | $5.63B | -15.9% |
| 2022 | $6.69B | +12.7% |
| 2021 | $5.93B | -6.1% |
| 2020 | $6.32B | -0.4% |
| 2019 | $6.34B | +34.9% |
| 2018 | $4.70B | +29.6% |
| 2017 | $3.63B | - |